Showing results (81-90 of 851) with videos related to
Sort By:
Pageof 86
Cancer Journal (Sudbury, Mass.)|January 30, 2019
Smoldering Multiple Myeloma: To Treat or Not to TreatPrashant Kapoor, S Vincent RajkumarLeukemia|July 23, 2025
Current risk stratification and staging of multiple myeloma and related clonal plasma cell disordersSaurabh Zanwar, S Vincent RajkumarBlood Reviews|September 2, 2023
Current approach to Waldenström macroglobulinemiaPrashant Kapoor, S Vincent RajkumarHematology/Oncology Clinics of North America|November 13, 2007
Management of newly diagnosed myelomaS Vincent Rajkumar, Antonio PalumboInternational Journal of Hematology|October 19, 2011
Update on risk stratification and treatment of newly diagnosed multiple myelomaPrashant Kapoor, S Vincent RajkumarClinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2017
New Developments in Diagnosis, Prognosis, and Assessment of Response in Multiple MyelomaOla Landgren, S Vincent RajkumarMayo Clinic Proceedings|February 5, 2019
Incidence of AL Amyloidosis in Olmsted County, Minnesota, 1990 through 2015Robert A Kyle, Dirk R Larson, Paul J Kurtin, et al.European Journal of Haematology|May 8, 2013
Differences in the distribution of cytogenetic subtypes between multiple myeloma patients with and without a family history of monoclonal gammopathy and multiple myelomaAlexandra J Greenberg, Margot Cousin, Shaji Kumar, et al.Leukemia Research|August 2, 2006
Cytokine and chemokine profiles in multiple myeloma; significance of stromal interaction and correlation of IL-8 production with disease progressionMichael Kline, Kathleen Donovan, Linda Wellik, et al.American Journal of Hematology|December 23, 2011
Sorafenib, a multikinase inhibitor, is effective in vitro against non-Hodgkin lymphoma and synergizes with the mTOR inhibitor rapamycinVijay Ramakrishnan, Michael Timm, Jessica L Haug, et al.Pageof 86